SPPD is a part of the Swedish AstraZeneca R&D that was closed in 2012. We have extensive experience in pharmaceutical development (AZ is one of the largest international pharma companies).

We develop pharmaceutical processes from raw material to the Active Pharmaceutical Ingredient (API) and from the API to the final formulation.

We are authorized to produce pharmaceuticals under Good Manufacturing Practice (GMP) up to 100 liter scale (GMP is a requirement from the authorities if the material is going to be used in clinical trials (in man)). This is quite unique for an institute.

In the context of Erifore one could either islolate potential pharmaceutical substances from forest raw material, alternatively use the raw material as starting material to more complex molecules. In both cases GMP production will be required to conduct clinical trials in man. SPPD can design the complete process at laboratory scale starting with the raw materials and then through the whole value chain to the final API in the applicable administration form (for example a tablet). Once the process is designed and optimized at laboratory scale the process will be scaled up and adequate material produced for the clinical trials (up to 100 liter scale at SPPD).